Boston, MA, United States of America

Invicro, LLC

Calculating rank
USPTO Granted Patents = 7

% Expired Patents = 42.9


Trademarks = 4

Forward Citations = 16

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal John William Hoppin (7 out of 15 patents)

silverMedal Harrison H Barrett (5 out of 28 patents)

bronzeMedal Yijun Ding (5 out of 5 patents)

4.  Luca Caucci (5 out of 9 patents)

5.  Jacob Yost Hesterman (2 out of 7 patents)

6.  Liying Chen (2 out of 11 patents)

7.  Brian Miller (2 out of 4 patents)

8.  Robert William Holt (1 out of 4 patents)

9.  Mohammed Q Qutaish (1 out of 4 patents)

10.  Marc Edward Seaman (1 out of 4 patents)

11.  Kelly Davis Orcutt (1 out of 2 patents)

12.  Christian Lackas (1 out of 2 patents)


7 patents:

Company Overview
Invicro is a leading provider of imaging services and software for research and drug development in the life sciences industry. With a focus on innovative technology and advanced analytics, Invicro helps clients enhance their understanding of disease, improve patient outcomes, and accelerate the discovery and development of new therapies. Founded in 2008, Invicro has established itself as a trusted partner for pharmaceutical and biotechnology companies, academic institutions, and research organizations worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

7 Patents

#247 in Boston, MA

#2,309 in Massachusetts

#40,027 in US

Boston, MA (US)
Boston, MA, United States of America
Forward Citations = 16

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Invicro, LLC. Retrieved from https://idiyas.com/company/invicro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…